Relevance of Behavioral Research in the Evolving State of Anti-obesity Medications: Is the Glass Half Empty or Half Full?

Michelle Y Martin; Renee J Rogers

doi:10.1093/abm/kaae022

Relevance of Behavioral Research in the Evolving State of Anti-obesity Medications: Is the Glass Half Empty or Half Full?

Ann Behav Med. 2024 May 15:kaae022. doi: 10.1093/abm/kaae022. Online ahead of print.

Authors

Michelle Y Martin¹, Renee J Rogers²

Affiliations

¹ Department of Preventive Medicine, University of Tennessee Health Science Center.
² Division of Physical Activity and Weight Management, Department of Internal Medicine, University of Kansas Medical Center.

PMID: 38748566
DOI: 10.1093/abm/kaae022

Abstract

Obesity continues to be a significant public health challenge. While weight loss medications have been studied and available for several years, the newest generation of highly effective anti-obesity medications (AOMs) will shift how behavioral science professionals approach obesity treatment and research. With the unique skill set of behavioral science professionals, this commentary suggests ways to integrate behavioral science into the rapidly evolving landscape of AOM use to accelerate better obesity care and generate new lines of research. The goal of this commentary is to stimulate discussion and encourage responsive and relevant action to improve population health.

Keywords: Anti-obesity medications; Behavior; Behavior Science; Lifestyle; Obesity; Research.

© Society of Behavioral Medicine 2024. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.